Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Publication year range
1.
Arch Oral Biol ; 55(7): 486-93, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20435295

ABSTRACT

OBJECTIVE: To evaluate patients with Diabetes Mellitus type 2 and painful peripheral neuropathy in order to investigate oral complaints and facial somatosensory findings. RESEARCH DESIGN AND METHODS: Case-control study; 29 patients (12 women, mean age 57.86 yo) with Diabetes Mellitus type 2 and 31 age-gender-matched controls were evaluated with a standardized protocol for general characteristics, orofacial pain, research diagnostic criteria for temporomandibular disorders, visual analogue scale and McGill Pain questionnaire, and a systematic protocol of quantitative sensory testing for bilateral facial sensitivity at the areas innervated by the trigeminal branches, which included the thermal detection by ThermoSensi 2, tactile evaluation with vonFrey filaments, and superficial pain thresholds with a superficial algometer (Micromar). Statistical analysis was performed with Wilcoxon, chi-square, confidence intervals and Spearman (p<0.05). RESULTS: Orofacial pain was reported by 55.2% of patients, and the most common descriptor was fatigue (50%); 17.2% had burning mouth. Myofascial temporomandibular disorders were diagnosed in 9 (31%) patients. The study group showed higher sensory thresholds of pain at the right maxillary branch (p=0.017) but sensorial differences were not associated with pain (p=0.608). Glycemia and HbA(1c) were positively correlated with the quantitative sensory testing results of pain (p<0.05) and cold (p=0.044) perceptions. Higher pain thresholds were correlated with higher glycemia and glycated hemoglobin (p=0.027 and p=0.026). CONCLUSIONS: There was a high prevalence of orofacial pain and burning mouth was the most common complaint. The association of loss of pain sensation and higher glycemia and glycated hemoglobin can be of clinical use for the follow-up of DM complications.


Subject(s)
Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/complications , Trigeminal Neuralgia/diagnosis , Adult , Aged , Blood Glucose/analysis , Burning Mouth Syndrome/diagnosis , Case-Control Studies , Diabetes Mellitus, Type 2/blood , Face/innervation , Facial Pain/diagnosis , Fatigue/diagnosis , Female , Glycated Hemoglobin/analysis , Humans , Male , Maxillary Nerve/physiopathology , Middle Aged , Pain Measurement , Pain Threshold/physiology , Sensory Thresholds/physiology , Somatosensory Disorders/diagnosis , Temporomandibular Joint Disorders/diagnosis , Thermosensing/physiology , Touch/physiology , Trigeminal Neuralgia/etiology
2.
Pain ; 123(1-2): 64-74, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16563629

ABSTRACT

The susceptibility of changes in responsiveness to noxious cold stimulation of rats submitted to chronic constriction of the infraorbital nerve (CION) or carrageenan to drug inhibition was compared. Nocifensive responses were measured as total time rats engaged in bilateral facial grooming with both forepaws over the first 2 min following tetrafluoroethane spray application to the snout. Carrageenan (50 microg, s.c. into upper lip) caused short-lived ipsilateral cold hyperalgesia (peak at 3 h: vehicle 8.4+/-1.3, carrageenan 21.2+/-3.0 s) which was markedly suppressed by i.p. indomethacin (4 mg/kg), celecoxib (10mg/kg) or s.c. dexamethasone (0.5 mg/kg), endothelin ET(A) or ET(B) receptor antagonists (BQ-123 and BQ-788, respectively; 10 nmol/lip). CION caused ipsilateral cold hyperalgesia between Days 2 and 12, which peaked on Days 4 (sham 15.3+/-1.8, CION 32.4+/-5.3s) to 6. Established peak CION-induced cold hyperalgesia was unaffected by indomethacin and celecoxib, whereas dexamethasone, BQ-123, BQ-788, and i.v. injections of selective antagonists of ET(A) (atrasentan, 3-10 mg/kg) or ET(B) (A-192621, 5-20 mg/kg) receptors caused significant inhibitions lasting 1-2.5h (peaks approximately 65-90%). Bosentan (dual ET(A)/ET(B) receptor antagonist, 10 mg/kg, i.v.) abolished CION-induced cold hyperalgesia for up to 6h. Thus, once established, CION-induced orofacial hyperalgesia to cold stimuli appears to lack an inflammatory component, but is alleviated by endothelin ET(A) and/or ET(B) receptor antagonists. If this CION injury model bears predictive value to trigeminal neuralgia (i.e., paroxysmal orofacial pain triggered by various stimuli), endothelin receptors might constitute new targets for treatment of this disorder.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Carrageenan/toxicity , Cold Temperature/adverse effects , Grooming/drug effects , Hyperalgesia/drug therapy , Maxillary Nerve/physiopathology , Nerve Compression Syndromes/drug therapy , Receptor, Endothelin A/drug effects , Receptor, Endothelin B/drug effects , Trigeminal Neuralgia/drug therapy , Animals , Atrasentan , Bosentan , Celecoxib , Dexamethasone/therapeutic use , Disease Models, Animal , Drug Evaluation, Preclinical , Endothelin-1/pharmacology , Endothelins/pharmacology , Hyperalgesia/physiopathology , Indomethacin/therapeutic use , Male , Nerve Compression Syndromes/physiopathology , Oligopeptides/pharmacology , Oligopeptides/therapeutic use , Peptide Fragments/pharmacology , Peptides, Cyclic/pharmacology , Peptides, Cyclic/therapeutic use , Piperidines/pharmacology , Piperidines/therapeutic use , Pyrazoles/therapeutic use , Pyrrolidines/pharmacology , Pyrrolidines/therapeutic use , Rats , Rats, Wistar , Receptor, Endothelin A/physiology , Receptor, Endothelin B/physiology , Sulfonamides/pharmacology , Sulfonamides/therapeutic use , Trigeminal Neuralgia/physiopathology
3.
Clin Neurol Neurosurg ; 108(8): 721-5, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16446028

ABSTRACT

Idiopathic trigeminal neuralgia (ITN) is a well-known disease often treated with neurosurgical procedures, which may produce sensorial abnormalities, such as numbness, dysesthesia and taste complaints. We studied 12 patients that underwent this technique, in order to verify pain, gustative and olfactory thresholds abnormalities, with a follow-up of 120 days. We compared the patients with a matched control group of 12 patients. Our results found a significant difference in the olfactory threshold at the immediate post-operative period (p=0.048). We concluded that injured trigeminal fibers are probably associated with the increase in the olfactory threshold after the surgery, supporting the sensorial interaction theory.


Subject(s)
Catheterization/methods , Nerve Block/methods , Postoperative Complications/diagnosis , Sensory Thresholds/physiology , Smell/physiology , Trigeminal Ganglion , Trigeminal Neuralgia/therapy , Adult , Aged , Aged, 80 and over , Chorda Tympani Nerve/physiopathology , Female , Humans , Male , Maxillary Nerve/physiopathology , Middle Aged , Pain Threshold/physiology , Pain, Postoperative/diagnosis , Pain, Postoperative/physiopathology , Postoperative Complications/physiopathology , Pressure , Taste Buds/physiopathology , Taste Threshold/physiology , Trigeminal Ganglion/physiopathology , Trigeminal Neuralgia/diagnosis , Trigeminal Neuralgia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL